학술논문
Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: Final analysis of a multicentre, open-label, single-arm, phase 2 trial
Document Type
Abstract
Author
Source
In Gynecologic Oncology October 2020 159 Supplement 1:6-7
Subject
Language
ISSN
0090-8258